Evidence map›Paper›PMID 41792386›Full record

ArticleScientific reports2026

The use of screening tests in panel studies to monitor cognitive functioning in senior participation programme groups using ACE-III and M-ACE.

Beata Kaczmarek, Zofia Ilkowska-Adamczewska, Agnieszka Remlinger-Molenda, Aleksandra Kaluzniak-Szymanowska, Katarzyna Stachnik, Katarzyna Wieczorowska-Tobis, Slawomir Tobis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Beata KaczmarekChair and Department of Palliative Medicine, Poznan University of Medical Sciences, Rusa 55, Poznan, 61-245, Poland. be.kaczmarek@gmail.com.ORCID http://orcid.org/0000-0002-4217-0871
Zofia Ilkowska-AdamczewskaChair and Department of Palliative Medicine, Poznan University of Medical Sciences, Rusa 55, Poznan, 61-245, Poland.ORCID http://orcid.org/0000-0002-6167-6966
Agnieszka Remlinger-MolendaDepartment of Adult Psychiatry, Poznan University of Medical Sciences, Szpitalna 27/33, Poznan, 60-572, Poland.ORCID http://orcid.org/0000-0003-1724-0644
Aleksandra Kaluzniak-SzymanowskaChair and Department of Palliative Medicine, Poznan University of Medical Sciences, Rusa 55, Poznan, 61-245, Poland.ORCID http://orcid.org/0000-0002-2663-5237
Katarzyna StachnikChair and Department of Palliative Medicine, Poznan University of Medical Sciences, Rusa 55, Poznan, 61-245, Poland.ORCID http://orcid.org/0000-0003-3081-7938
Katarzyna Wieczorowska-TobisChair and Department of Palliative Medicine, Poznan University of Medical Sciences, Rusa 55, Poznan, 61-245, Poland.ORCID http://orcid.org/0000-0003-4017-3013
Slawomir TobisDepartment of Occupational Therapy, Poznan University of Medical Sciences, Swiecickiego 6, Poznan, 60-781, Poland.ORCID http://orcid.org/0000-0002-0764-3258

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using a longitudinal approach, this study compares cognitive screening tests (MMSE, ACE-III, M-ACE) in older patients. A total of 138 participants (112 women, 26 men; mean age 73.2 ± 7.4 years) underwent two examinations with a 13-month interval. Status change between health, MCI, and dementia categories was analysed. Significant shifts in categorisation were observed for MMSE and ACE-III (survey 1: χ² = 9.03, p = 0.0027; survey 2: χ² = 4.00, p = 0.0455), with more participants scoring lower on ACE-III. Similar shifts occurred for M-ACE (survey 1: χ² = 11.28, p = 0.0008; survey 2: χ² = 4.36, p = 0.0367). The ROC curve showed high AUC values for ACE-III and M-ACE (0.892 ± 0.031; 0.908 ± 0.027, respectively), with consistent sensitivity and specificity (p = 0.1516; p = 0.4534, respectively). ACE-III and M-ACE exhibited high sensitivity and specificity compared to MMSE with significant transitions indicating a high-risk group for dementia.

Indexed as

CognitionCognitive DysfunctionDementiaAgedAged, 80 and overFemaleHumansLongitudinal StudiesMaleMass ScreeningNeuropsychological TestsROC CurveSensitivity and SpecificityAlzheimer’s diseaseDementiaNeurocognitive disordersScreening tests

Identifiers

PMID41792386
PMCPMC13083905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.